Download Sample
Loading...
| A05268 | Pages: 212 | Nov 2019 | 2984 Views | | |
| Author(s) : Kavita Joshi , Onkar Sumant | Tables: 89 | Charts: 35 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Protein Sequencing Market
Request Now !The global protein sequencing market size was valued at $ 5,399.9 million in 2018 and is expected to reach $ 9,926.7 million by 2026, registering a CAGR of 7.8% from 2019 to 2026. Protein sequencing is a de novo sequencing method for determination and analysis of the amino acid sequence from the mass spectrum. The process enables researchers to obtain information about protein conformation. Protein sequencing has established itself as a high-throughput proteomic technique and has several applications. One of the prominent applications is in target-based drug discovery. A range of various computational methods and experimental methods, notably Edman degradation and mass spectrometry, are used for protein sequencing. Several biotechnology and pharmaceutical companies are making sizeable investments on utilizing protein sequencing in drug development. Further, innovative developments in high-throughput technologies has allowed rapid and parallel sequencing of proteins. High-resolution sequencing of even small amounts of protein can help in characterization of gene products and subcellular structures.
Get more information on this report : Request Sample Pages
Increasing focus on target-based drug development activities by biotechnology and pharmaceutical companies in various developing and developed regions is a key factor driving the protein sequencing market. Recent advances in de novo peptide-sequencing methods and analytical methods, with the application of neural networks, have opened new avenues in the market. Technological advances in mass spectrometer is a case in point. In addition, progressions in nanopore sensors and single-molecule fluorescence devices is able to detect specific residues on a peptide. Rising funding on proteomics research in numerous developing and developed nations is a key factor boosting the market. Rise in demand for protein biomarkers in the drug development process is a key trend fueling the rapid expansion of the protein sequencing market. However, the uptake of protein sequencing method is restricted by the high cost of infrastructures and equipment, such as that of mass spectrometers. Further, monitoring peptide location and positioning is a crucial technical obstacle in the development of next-generation protein-sequencing modalities. The growing application of protein sequencing technique for identifying novel peptides in human antibodies and antigens is also boosting the protein sequencing market. Furthermore, the paucity of adequate technological expertise and laboratory infrastructures in some parts of the world are factors that hinder the market to realize its full potential. Nevertheless, technological advancements for the identification of isobaric residues in protein sequences are expected to unlock vast potential prospects in the global protein sequencing market.
Global Protein Sequencing Market Segmentation
The protein sequencing market is segmented based on product & service, technology, application, end user, and region. Based on products and services, the market is divided into reagents and consumables, instruments, analysis product, protein sequencing services. In addition, the instrument segment is further bifurcated into Edman degradation and mass spectrometry. Based on technology, the market is categorized into mass spectrometry and Edman degradation. Based on application, the market is bifurcated into academia research, biopharmaceuticals and biotechnology research. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Technology segment review
By technology, the Edman degradation segment accounted for 58% of the total market share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to its wide usage for protein sequencing. Further, the Edman degradation is the most significant technique in protein sequence analysis. It includes stepwise degradation of peptides with phenyl isothiocyanate, starting at the N-terminus of the polypeptide. However, the mass spectrometry market is anticipated to grow at the fastest growth rate during the forecast period. This is attributed to the increased usage of mass spectrometry technique for fast, rapid, and long chain protein sequencing.
Get more information on this report : Request Sample Pages
Application segment review
Based on protein sequencing market analysis, by application, the biopharmaceuticals segment dominated the protein sequencings market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the increased usage of protein sequencing in development of novel biotherapeutics. Further, the classification of biologic drugs by protein digestion to their component peptides is essential to ensure a full sequence coverage of the biopharmaceutical molecule.
North America is the leading revenue contributor to the global protein sequencing market, owing to technological advancements in sequencing platforms and increase in applications of protein sequencing in this region. Europe has the second largest share in the global market. Increase in demand for protein sequencing along with surging awareness are the key factors that are expected to fuel the growth of the protein sequencing market in Europe region.
Get more information on this report : Request Sample Pages
Comprehensive competitive analysis and profiles of major market players such as Bioinformatics Solutions Inc., Charles River Laboratories, Agilent Technologies, Inc., Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters Corporation are some of the key players in the global protein sequencing market are provided in this report
Get more information on this report : Request Sample Pages
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Market Share Analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increasing focus on target-based drug development
3.4.1.2. Advancements in mass spectrometry and analytical techniques
3.4.2. Restraints
3.4.2.1. Dearth of skilled researchers and laboratory professionals
3.4.3. Opportunities
3.4.3.1. Opportunity in computational proteomics
CHAPTER 4: PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents & Consumables
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Edman Degradation
4.3.4.1. Market size and forecast
4.3.5. Mass Spectrometry
4.3.5.1. Market size and forecast
4.4. Analysis Product
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Protein sequencing services
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: PROTEIN SEQUENCING MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Mass Spectrometry
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Edman Degradation
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: PROTEIN SEQUENCING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Biopharmaceuticals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Biotechnology Research
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
CHAPTER 7: PROTEIN SEQUENCING MARKET BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S. protein sequencing market, by products & services
7.2.2.2. U.S. protein sequencing market, by technology
7.2.2.3. U.S. protein sequencing market, by application
7.2.2.4. Canada protein sequencing market, by products & services
7.2.2.5. Canada protein sequencing market, by technology
7.2.2.6. Canada protein sequencing market, by application
7.2.2.7. Mexico protein sequencing market, by products & services
7.2.2.8. Mexico protein sequencing market, by technology
7.2.2.9. Mexico protein sequencing market, by application
7.2.3. North America protein sequencing market, by Products & Services
7.2.4. North America protein sequencing market, by technology
7.2.5. North America protein sequencing market, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany protein sequencing market, by products & services
7.3.2.2. Germany protein sequencing market, by technology
7.3.2.3. Germany protein sequencing market, by application
7.3.2.4. France protein sequencing market, by products & services
7.3.2.5. France protein sequencing market, by technology
7.3.2.6. France protein sequencing market, by application
7.3.2.7. UK protein sequencing market, by products & services
7.3.2.8. UK protein sequencing market, by technology
7.3.2.9. UK protein sequencing market, by application
7.3.2.10. Italy protein sequencing market, by products & services
7.3.2.11. Italy protein sequencing market, by technology
7.3.2.12. Italy protein sequencing market, by application
7.3.2.13. Rest of Europe protein sequencing market, by products & services
7.3.2.14. Rest of Europe protein sequencing market, by technology
7.3.2.15. Rest of Europe protein sequencing market, by application
7.3.3. Europe protein sequencing market, by products & services
7.3.4. Europe protein sequencing market, by technology
7.3.5. Europe protein sequencing market, by application
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan protein sequencing market, by products & services
7.4.2.2. Japan protein sequencing market, by technology
7.4.2.3. Japan protein sequencing market, by application
7.4.2.4. China protein sequencing market, by products & services
7.4.2.5. China protein sequencing market, by technology
7.4.2.6. China protein sequencing market, by application
7.4.2.7. Australia protein sequencing market, by products & services
7.4.2.8. Australia protein sequencing market, by technology
7.4.2.9. Australia protein sequencing market, by application
7.4.2.10. South Korea protein sequencing market, by products & services
7.4.2.11. South Korea protein sequencing market, by technology
7.4.2.12. South Korea protein sequencing market, by application
7.4.2.13. Rest of Asia-Pacific protein sequencing market, by products & services
7.4.2.14. Rest of Asia-Pacific protein sequencing market, by technology
7.4.2.15. Rest of Asia-Pacific protein sequencing market, by application
7.4.3. Asia-Pacific protein sequencing market, by products & services
7.4.4. Asia-Pacific protein sequencing market, by technology
7.4.5. Asia-Pacific protein sequencing market, by application
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil protein sequencing market, by products & services
7.5.2.2. Brazil protein sequencing market, by technology
7.5.2.3. Brazil protein sequencing market, by application
7.5.2.4. Saudi Arabia protein sequencing market, by products & services
7.5.2.5. Saudi Arabia protein sequencing market, by technology
7.5.2.6. Saudi Arabia protein sequencing market, by application
7.5.2.7. South Africa protein sequencing market, by products & services
7.5.2.8. South Africa protein sequencing market, by technology
7.5.2.9. South Africa protein sequencing market, by application
7.5.2.10. Rest of LAMEA protein sequencing market, by products & services
7.5.2.11. Rest of LAMEA protein sequencing market, by technology
7.5.2.12. Rest of LAMEA protein sequencing market, by application
7.5.3. LAMEA protein sequencing market, by products & services
7.5.4. LAMEA protein sequencing market, by technology
7.5.5. LAMEA protein sequencing market, by application
CHAPTER 8: COMPANY PROFILES
8.1. CHARLES RIVER LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. SHIMADZU Corp.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Agilent Technologies (USA)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Thermo Fischer Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Selvita (SA)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Rapid novor.
8.6.1. Company overview:
8.6.2. Company snapshot:
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. SGS (SA)
8.7.1. Company overview
8.7.2. Company Snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. Proteome Factory
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. Bioinformatics solution
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. Water Corporation
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
LIST OF TABLES
TABLE 01. PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 02. REAGENTS & CONSUMABLES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. GLOBAL PROTEIN SEQUENCING MARKET, FOR INSTRUMENTS, BY REGION, 2018–2026 ($MILLION)
TABLE 04. GLOBAL PROTEIN SEQUENCING MARKET, FOR ANALYSIS PRODUCT BY REGION, 2018–2026 ($MILLION)
TABLE 05. GLOBAL PROTEIN SEQUENCING MARKET, FOR PROTEIN SEQUENCING SERVICES BY REGION, 2018–2026 ($MILLION)
TABLE 06. PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 07. MASS SPECTROMETRY PROTEIN SEQUENCING MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 08. GLOBAL PROTEIN SEQUENCING MARKET, FOR EDMAN DEGRADATION, BY REGION, 2018–2026 ($MILLION)
TABLE 09. PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 10. PROTEIN SEQUENCING MARKET, FOR BIOPHARMACEUTICALS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL PROTEIN SEQUENCING MARKET, FOR BIOTECHNOLOGY RESEARCH, BY REGION, 2018–2026 ($MILLION)
TABLE 12. PROTEIN SEQUENCING MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA PROTEIN SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 14. U.S. PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 15. U.S. PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 16. U.S. PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 17. CANADA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 18. CANADA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 19. CANADA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 20. MEXICO PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 21. MEXICO PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 22. MEXICO PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 23. NORTH AMERICA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 24. NORTH AMERICA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 25. NORTH AMERICA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26. EUROPE PROTEIN SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27. GERMANY PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 28. GERMANY PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 29. GERMANY PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 30. FRANCE PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 31. FRANCE PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 32. FRANCE PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 33. UK PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 34. UK PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 35. UK PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 36. ITALY PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 37. ITALY PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 38. ITALY PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39. REST OF EUROPE PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 40. REST OF EUROPE PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 41. REST OF EUROPE PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 42. EUROPE PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 43. EUROPE PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 44. EUROPE PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 45. ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. JAPAN PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 47. JAPAN PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 48. JAPAN PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 49. CHINA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 50. CHINA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 51. CHINA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 52. AUSTRALIA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 53. AUSTRALIA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 54. AUSTRALIA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 55. SOUTH KOREA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 56. SOUTH KOREA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 57. SOUTH KOREA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 58. REST OF ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 59. REST OF ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 60. REST OF ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 61. ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 62. ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 63. ASIA-PACIFIC PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 64. LAMEA PROTEIN SEQUENCING MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 65. BRAZIL PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 66. BRAZIL PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 67. BRAZIL PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 68. SAUDI ARABIA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 69. SAUDI ARABIA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 70. SAUDI ARABIA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 71. SOUTH AFRICA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 72. SOUTH AFRICA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 73. SOUTH AFRICA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 74. REST OF LAMEA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 75. REST OF LAMEA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 76. REST OF LAMEA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 77. LAMEA PROTEIN SEQUENCING MARKET, BY PRODUCTS & SERVICES, 2018–2026 ($MILLION)
TABLE 78. LAMEA PROTEIN SEQUENCING MARKET, BY TECHNOLOGY, 2018–2026 ($MILLION)
TABLE 79. LAMEA PROTEIN SEQUENCING MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 80. CHARLES RIVER LABORATORIES.: COMPANY SNAPSHOT
TABLE 81. CHARLES RIVER LABORATORIES: OPERATING SEGMENTS
TABLE 82. SHIMADZU CORP.: COMPANY SNAPSHOT
TABLE 83. AGILENT TECHNOLOGIES:COMPANY SNAPSHOT
TABLE 84. THERMO FISCHER: COMPANY SNAPSHOT
TABLE 85. THERMO FISCHER: OPERATING SEGMENTS
TABLE 86. SELVITA: COMPANY SNAPSHOT
TABLE 87. SELVITA: OPERATING SEGMENTS
TABLE 88. RAPID NOVOR: COMPANY SNAPSHOT
TABLE 89. RAPID NOVOR: OPERATING SEGMENTS
TABLE 90. SGS OPERATING SEGMENTS
TABLE 91. PROTEOME FACTORY COMPANY SNAPSHOT
TABLE 92. PROTEOME FACTORY OPERATING SEGMENTS
TABLE 93. BIOINFORMATICS SOLUTIONS INC COMPANY SNAPSHOT
TABLE 94. BIOINFORMATICS SOLUTIONS INC OPERATING SEGMENTS
TABLE 95. WATER CORPORATION: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 01. SEGMENTATION OF PROTEIN SEQUENCING
FIGURE 02. LOW-TO- MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. LOW BARGAINING POWER OF BUYER
FIGURE 04. MODERATE THREAT OF SUBSTITUTES
FIGURE 05. LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH COMPETITIVE RIVALARY
FIGURE 07. MARKET SHARE ANALYSIS: PROTEIN SEQUENCING, 2018
FIGURE 08. DRIVERS AND RESTRAINTS: PROTEIN SEQUENCING MARKET
FIGURE 09. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR INSTRUMENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. GLOBAL EDMAN DEGRADATION MARKET, 2018–2026 ($MILLION)
FIGURE 12. GLOBAL MASS SPECTROMETRY MARKET, 2018–2026 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR ANALYSIS PRODUCTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR MASS SPECTROMETRY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR EDMAN DEGRADATION, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR ACADEMIC RESEARCH Y, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF PROTEIN SEQUENCING MARKET, FOR BIOTECHNOLOGY RESEARCH, BY COUNTRY, 2018 & 2026 (%)
FIGURE 19. CHARLES RIVER: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. CHARLES RIVER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 21. CHARLES RIVER LABORATORIES: REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 22. SHIMADZU.: NET SALES, 2017–2018 ($MILLION)
FIGURE 23. SHIMADZU.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. SHIMADZU CORP.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. AGILENT.: NET SALES, 2017–2018 ($MILLION)
FIGURE 26. AGILENT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. AGILENT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. THERMO FISCHER NET SALES, 2016–2018 ($MILLION)
FIGURE 29. THERMO FISCHER: REVENUE SHARE BY PRODUCT & SERVICES, 2018 (%)
FIGURE 30. THERMO FISCHER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. SELVITA NET SALES, 2016–2018 ($MILLION)
FIGURE 32. SGS COMPANY: NET SALES, 2016–2018 ($MILLION)
FIGURE 33. SGS: REVENUE SHARE BY PRODUCT & SERVICES, 2018 (%)
FIGURE 34. SGS REVENUE SHARE BY REGION, 2018 (%)
FIGURE 35. WATER CORPORATION: NET SALES, 2016–2018 ($MILLION)
Adoption of protein sequencing to determine protein structures and deduce new targeted drugs is expected to flourish the market growth in the near future. Technological advancements in the field of mass spectrometry are predicted to create numerous opportunities for the development of new targeted drugs.
The protein sequencing market is anticipated to witness rapid growth in the near future. Protein sequencing finds its application in various fields including biotherapeutics, genetic engineering, and many others. Further, peptide mapping or protein sequencing is a critical step during biotherapeutic characterization. The characterization of biologic drugs by using protein sequencing to their constituent peptides is essential to ensure a complete sequence coverage of the biopharmaceutical molecule. Further, from drug discovery and development, through the clinical testing phase and to bioproduction and QA/QC, peptide mapping remains a crucial analytical method. Key manufacturers such as Thermo Fisher, are focusing on development of unique combination of innovative technologies in a start-to-finish workflow that is designed to be fast, reliable, reproducible, and easy to use.
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Enterprise
License/PDF
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers